300832 Stock Overview
A bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in the People's Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Shenzhen New Industries Biomedical Engineering Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥67.80 |
| 52 Week High | CN¥97.20 |
| 52 Week Low | CN¥58.31 |
| Beta | -0.41 |
| 1 Month Change | 0.015% |
| 3 Month Change | -2.95% |
| 1 Year Change | -9.42% |
| 3 Year Change | 50.10% |
| 5 Year Change | n/a |
| Change since IPO | 185.00% |
Recent News & Updates
Investors Don't See Light At End Of Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Tunnel
Dec 15
Investors Shouldn't Overlook The Favourable Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832)
Nov 17Recent updates
Investors Don't See Light At End Of Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Tunnel
Dec 15Investors Shouldn't Overlook The Favourable Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832)
Nov 17Should You Be Adding Shenzhen New Industries Biomedical Engineering (SZSE:300832) To Your Watchlist Today?
Oct 14Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Aug 25A Look At The Intrinsic Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Jul 01Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today
Apr 09The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence
Mar 18Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Mar 01Shareholder Returns
| 300832 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -1.2% | -1.1% | -0.6% |
| 1Y | -9.4% | -9.0% | 11.3% |
Return vs Industry: 300832 matched the CN Medical Equipment industry which returned -9% over the past year.
Return vs Market: 300832 underperformed the CN Market which returned 11.3% over the past year.
Price Volatility
| 300832 volatility | |
|---|---|
| 300832 Average Weekly Movement | 7.7% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300832 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300832's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,627 | Wei Rao | www.snibe.com |
Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in the People's Republic of China and internationally. It offers immunoassay, biochemistry/electrolyte, molecular diagnostics, point of care testing, lab automation, and integrated system, products. The company was founded in 1995 and is headquartered in Shenzhen, the People's Republic of China.
Shenzhen New Industries Biomedical Engineering Co., Ltd. Fundamentals Summary
| 300832 fundamental statistics | |
|---|---|
| Market cap | CN¥53.27b |
| Earnings (TTM) | CN¥1.85b |
| Revenue (TTM) | CN¥4.44b |
28.8x
P/E Ratio12.0x
P/S RatioIs 300832 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300832 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.44b |
| Cost of Revenue | CN¥1.20b |
| Gross Profit | CN¥3.23b |
| Other Expenses | CN¥1.38b |
| Earnings | CN¥1.85b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.36 |
| Gross Margin | 72.86% |
| Net Profit Margin | 41.72% |
| Debt/Equity Ratio | 0% |
How did 300832 perform over the long term?
See historical performance and comparison